公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
公司地址 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
電話號碼 +1 201 847-6800
傳真號碼 --
公司網頁 http://www.bd.com
員工數量 72000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Thomas E. Polen, Jr Chairman of the Board, Chief Executive Officer and President 美元 1.40M 18/12/2025
Mr. Roland Goette Executive Vice President and President, EMEA -- 25/11/2025
Mr. Bilal Muhsin Executive Vice President and President, Connected Care Segment -- 25/11/2025
Ms. Shana Carol Neal Executive Vice President and Chief People Officer -- 25/11/2025
Mr. Antoine C. Ezell Executive Vice President, President, North America and Chief Marketing Officer -- 25/11/2025
Mr. Pavan Kumar Mocherla Executive Vice President and President, Greater Asia -- 25/11/2025
Mr. David Shan Executive Vice President and Chief Integrated Supply Chain Officer -- 25/11/2025
Ms. Michelle Quinn Executive Vice President and General Counsel -- 27/11/2024
Ms. Pamela L. Spikner Senior Vice President, Chief Accounting Officer and Controller -- 25/11/2025
Mr. Michael Feld Executive Vice President and President, Life Sciences 美元 775.00K 25/11/2025
Mr. Vitor Roque Senior Vice President of Finance, Business Units, Corporate Financial Planning, Analysis and Interim Chief Financial Officer -- 15/10/2025
 
董事會成員
董事會 職務 更新日期
Mr. Bertram L. Scott Lead Independent Director 18/12/2025
Mr. Timothy M. Ring Independent Director 18/12/2025
Mr. William M. Brown Independent Director 18/12/2025
Mr. Gregory J. Hayes Independent Director 18/12/2025
Mr. Jeffrey W. Henderson Independent Director 18/12/2025
Mr. R. Andrew Eckert Independent Director 18/12/2025
Mr. Christopher Ian Montague Jones Independent Director 18/12/2025
Mr. Thomas E. Polen, Jr Chairman of the Board, Chief Executive Officer and President 18/12/2025
Ms. Jacqueline Wright Independent Director 17/11/2025
Dr. Carrie L. Byington Independent Director 18/12/2025
Dr. Joanne Waldstreicher, M.D. Independent Director 18/12/2025
Mr. Robert L. Huffines Independent Director 17/11/2025
 
所屬ETF (更新日期: 07/11/2026 02:32)
代號 名稱 佔比% ▼ 持有日期
JLVPJPMorgan U.S. Large Cap Value Plus ETF0.0004%30/10/2026
UDIVFranklin US Core Dividend Tilt Index ETF0.0003%31/10/2026
RAFEPIMCO RAFI ESG US ETF0.0003%30/10/2026
IQSZInvesco Global Equity Net Zero ETF0.0003%30/10/2026
FTCEFirst Trust New Cstrcts Cr Erns Ldrs ETF0.0003%29/10/2026
WAMAWisdomTree U.S. Adaptive Moving Average0.0003%30/10/2026
TOKiShares MSCI Kokusai ETF0.0003%30/10/2026
ACVFAmerican Conservative Values ETF0.0003%30/10/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0003%30/10/2026
YOKEYoke Core ETF0.0003%30/10/2026
GEQCambria Global EW 2 ETF0.0003%30/10/2026
AVSUAvantis Responsible US Equity ETF0.0002%30/10/2026
NQLTNeuberger Quality Select ETF0.0002%31/10/2026
ONOFGlobal X Adaptive US Risk Management ETF0.0002%30/10/2026
GMOVGMO U.S. Value ETF0.0002%30/09/2026
PEPSParametric Equity Plus ETF0.0002%30/10/2026
NACPImpact Shares NAACP Minority Empwrmt ETF0.0002%30/10/2026
DFVEDoubleLine Fortune 500 Equal Weight ETF0.0002%29/10/2026
AVUCAvantis U.S. Core Equity ET0.0002%30/10/2026
CSHPiShares Dynamic Short-Term Active ETF0.0002%28/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12   13    14    15    16    17  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.